Stop TB Partnership Working Group on New TB Vaccines

It's just over a week since we wrapped up the 7th #GlobalForumTBVaccine possible. Over 300 participants joined us at the Cidade Das Artes in Rio de Janeiro, Brazil, to explore the theme "Driving innovation from discovery to access". It was an inspiring week as we reflected on the promising science in the pipeline, from discovery to late-stage development and ongoing efforts to ensure new TB vaccines are accessible once available. Calls to action to finance TB vaccine development and ensure their equitable access were strongly aligned throughout the week, highlighting that the global is well aligned in pursuit of our shared mission to deliver new TB vaccine to end TB. A huge thank you to everyone who made the Forum possible, including the expert speakers, our dedicate planning and scientific advisory committees, the powerful action by the Community Engagement Committee and community members from around the world, and to our generous sponsors! We can't wait to share more reflections on this milestone event in the months to come!

Making sure that we eventually have new TB vaccines requires a multi-faceted approach. During the recently concluded 7th #GlobalForumTBVaccine we unpacked several contributing factors around this; 📢 The panel on our opening session brought up what is still needed to make TB vaccines a reality. 📢 The discussion session on 10th October tackled the need for us to move from political commitment to action to deliver new TB vaccines this decade. 📢 We ended things with Plenary 6 that looked at enabling TB vaccine development through funding, political will, open science, and engaged communities. 📑 In support of the fight towards making new TB vaccines a reality, Leigh Raithby from Results Canada shares her reflections on the 7th Global Forum on TB Vaccines on the Stop TB Canada website. 🔗 https://bit.ly/4eVTdBE

After a memorable time gathering together at the 7th #GlobalForumTBVaccines over 2 weeks ago, this week we want to reflect on several discussions and interactions that took place. 🩺 Sub-clinical TB is now being taken as a critical research gap since this form of TB also contributes to cases. 📢 Under one of our Plenary 3 talks, we got to hear from Gavin Churchyard at the The Aurum Institute on the implications of sub-clinical TB on vaccine trial design and development. 📑 The inclusion of sub-clinical TB as an endpoint in clinical trials still requires more evidence. We also need to think about adequate definitions of subclinical TB, especially in children and appropriate clinical trial design options to match this. 🧾 To delve more into these aspects have a look at the review published this October by Gavin Churchyard and colleagues around this topic. https://lnkd.in/djBSYP4v

Will you join over 1,300 supporters who have signed the declaration so far to help us reach 1,500? Today's your last chance to sign! Support the demands of the global TB community for the development and rollout of new TB vaccines. Sign the Community Declaration of the 7th #GlobalForumTBVax!  Read it in English, French, Hindi, Indonesian, Portuguese, Russian, and Spanish.   📅 Deadline to sign: Thursday, 10 October 2024    ✒️ bit.ly/7GFTBVcomdecSign 

As we enter the third and final day of the 7th #GlobalForumTBVaccines, we’ll be reflecting on a week of innovative science and the growing momentum in the field with clear agreement on the need for increased and sustained coordination across the breath of the TB vaccine research to implementation continuum. Today, we're bringing you the latest research, findings, and insights from TB vaccine science across seven engaging sessions and more than 40 speakers. Check out the program below.   📢 Plenary 5: Innovative approaches to TB vaccine development  🗣️ Oral Abstract 3: Improved formulation and delivery platforms, preclinical research  🗣️ Oral Abstract 4: Impact, implementation, policy   📢 Plenary 4: Country scale-up and implementation of new TB vaccines  💬 Discussion session 1: Accelerating clinical development of novel TB vaccines  💬 Discussion session 2: From political commitment to action to deliver new TB vaccines this decade  📢 Plenary 6: Enabling TB vaccine development through funding, political will, open science, and engaged communities  📢 Closing session 📅 Learn more at https://lnkd.in/eQV9D5ec 

It was an action packed first day at the first day of the 7th #GlobalForumTBVaccines with a host of experts from across the TB vaccine and global health field reflecting on the pivotal moment we find ourselves at in the field. Speakers shared optimism about the promising science in the pipeline alongside bold support for the full and active inclusion of affected communities in across the breadth of development to implementation activities. Coordination emerged as a key enabler across the sessions, form financing, to clinical trials and regulatory harmonization. On day 2 of the 7th #GlobalForumTBVaccines, we’ll be bringing you the latest research, findings, and insights from TB vaccine science across seven engaging sessions and more than 50 speakers. Check out the program below. 📢 Plenary 3: Advancing TB vaccine clinical development: Learning from experience and looking to the future 🗣️ Oral Abstract 1: Mechanisms of biomarkers and protection, novel approaches, human challenge, optimizing animal models 🗣️ Oral Abstract 2: Advancing clinical development 📢 Plenary 4: Country scale-up and implementation of new TB vaccines 🖼️ Poster discussion 1: Defining correlates of protection 🖼️ Poster discussion 2: Feeding the pipeline: New vaccines and platforms 🖼️ Poster discussion 3: Including and reaching populations with special considerations 📅 Learn more at https://lnkd.in/eQV9D5ec

Today’s the day! The 7th #GlobalForumTBVaccines opens its doors in just a few hours, live from Cidade das Artes, Rio de Janeiro! We’re thrilled to be welcoming over 350 participants from around the world for our dynamic three-day program, featuring a host of TB vaccine and global health experts, including a keynote address from Sir Jeremy Farrar, Chief Scientist, World Health Organization. Follow us on LinkedIn to learn more about what’s in store, including today’s program: 📢 Opening sessions & keynote address 📢 Plenary 1: From discovery to access 📢 Plenary 2: Global and regional enablers for the introduction of new TB vaccines 📅 Explore the full program at https://lnkd.in/eQV9D5ec

The 7th #GlobalForumTBVaccines kicks off tomorrow, live at Cidade das Artes, Rio de Janeiro! We’re excited to join over 350 participants from around the world for our dynamic three-day program. Follow us on LinkedIn to learn more about what’s in store, including:  📢 6 plenaries  🗣️ 4 oral abstract sessions  📋 6 discussion sessions  🖼️ More than 60 posters  🤲 Interventions from our community engagement committee 📅 Explore the program https://lnkd.in/eQV9D5ec 

We extend our sincere gratitude to our sponsors for helping make the 7th#GlobalForumTBVaccines possible. It is through their generous support that we’ve been able to put together the most comprehensive Global Forum agenda yet, all taking place in the world renowned Cidade das Artes in Rio de Janeiro, Brazil. We can't wait to open the Forum this coming Tuesday, 8 October. Find out more 👉 https://lnkd.in/d8gx6ej

Thanks to our sponsor Biofabri (part of ZENDAL) for their generous support in making the 7th #GlobalForumTBVaccines possible! Biofabri leads with a vision to develop & manufacture human vaccines, inc. sponsoring the #MTBVAC TB vaccine. Learn more: https://lnkd.in/d8gx6ej